Haematopoietic stem cells are progenitor cells that have the ability to both generate all types of blood cells, including those of the myeloid and lymphoid lineages, and to replace themselves. In ...
Drug tolerance to KRAS inhibition remains a major challenge in cancer therapy. Here the authors find that KRAS inhibition induces a cellular state characterized by enhanced ribosome biogenesis in KRAS ...
The FDA has authorized Mayo Clinic to offer mesenchymal stem cells as part of the Regenerative Nephrology Compassionate Use Program. This is an expanded access program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback